5-[[1-[2-[(3R)-3-aminobutyl]-5-fluoro-3-pyridinyl]cyclopropyl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid
C19H21FN6O2 — CID 155675991
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[1-[2-[(3R)-3-aminobutyl]-5-fluoro-3-pyridinyl]cyclopropyl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid
5-[[1-[2-[(3R)-3-aminobutyl]-5-fluoro-3-pyridinyl]cyclopropyl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (PubChem CID 155675991) has the molecular formula C19H21FN6O2 and a molecular weight of 384.42 g/mol. Its IUPAC name is 5-[[1-[2-[(3R)-3-aminobutyl]-5-fluoro-3-pyridinyl]cyclopropyl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid.
Molecular Properties
| Compound Name | 5-[[1-[2-[(3R)-3-aminobutyl]-5-fluoro-3-pyridinyl]cyclopropyl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid |
|---|---|
| PubChem CID | 155675991 |
| Molecular Formula | C19H21FN6O2 |
| Molecular Weight | 384.42 g/mol |
| Exact Mass | 384.17 |
| IUPAC Name | 5-[[1-[2-[(3R)-3-aminobutyl]-5-fluoro-3-pyridinyl]cyclopropyl]amino]pyrazolo[1,5-a]pyrimidine-3-carboxylic acid |
| SMILES | C[C@@H](N)CCc1ncc(F)cc1C1(Nc2ccn3ncc(C(=O)O)c3n2)CC1 |
| InChI | InChI=1S/C19H21FN6O2/c1-11(21)2-3-15-14(8-12(20)9-22-15)19(5-6-19)25-16-4-7-26-17(24-16)13(10-23-26)18(27)28/h4,7-11H,2-3,5-6,21H2,1H3,(H,24,25)(H,27,28)/t11-/m1/s1 |
| InChIKey | UMZVSSDQKFZZAW-LLVKDONJSA-N |
| XLogP | 2.34 |
| TPSA | 118.43 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.42 |
| LogP ≤ 5 | 2.34 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155675991 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.